NCT03465878View on ClinicalTrials.gov

A Study of LY900014 in Participants With Type 1 Diabetes Mellitus

PHASE1CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

March 26, 2018

Primary Completion Date

November 14, 2019

Study Completion Date

November 14, 2019

Conditions
Type 1 Diabetes Mellitus
Interventions
DRUG

LY900014

Administered via SC injection

DRUG

Insulin Lispro

Administered via SC injection

Trial Locations (2)

30173

Kinderkrankenhaus auf der Bult, Hanover

M4G 3E8

LMC Endocrinology Centres Ltd., Toronto

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT03465878 - A Study of LY900014 in Participants With Type 1 Diabetes Mellitus | Biotech Hunter | Biotech Hunter